share_log

Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vivo Opportunity Fund Holdings, L.P.(9.99%),Vivo Opportunity, LLC(9.99%)

Unicycive Therapeutics | SC 13G:超過5%持股股東披露文件-Vivo Opportunity Fund Holdings, L.P.(9.99%),Vivo Opportunity, LLC(9.99%)

SEC announcement ·  2023/07/14 16:30
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息